Pinpointing the precise culprits behind harmful biological processes—such as excessive scarring (fibrosis) in organs like the ...

Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic.

Our immune system is designed to protect us by recognizing and attacking infected or abnormal cells. However, cancer cells ...

BioVaxys stands at the forefront of innovation with its mission to develop advanced treatments in oncology, infectious disease, antigen desensitization, allergy, autoimmune diseases, and other immune ...

Abnormal CTU2 expression in tumors is associated with alterations in immune cell infiltration, immune evasion, and immunotherapy response. CTU2 may contribute to several key cancer-related pathways ...